IPO

Clinitech Laboratory Limited IPO

BSE SME

Listed On: Aug 1, 2024 at ₹ 115.0

₹ 230400 /2400 Shares
*Min Investment

Check Allotment

25 Jul, 2024

Open Date

29 Jul, 2024

Close Date

30 Jul, 2024

Allotment Date

01 Aug, 2024

Listing Date
Clinitech Laboratory Limited IPO Issue Details
  • Issue Price ₹96 per equity share
  • Face Value ₹10 Per Equity Share
  • Total Issue Size 6,02,400 shares(aggregating up to ₹5.78 crore)
  • Fresh Share 6,02,400 shares(aggregating up to ₹5.78 crore)
  • Listing at BSE SME
  • List Price 115.0
  • Listing Date 2024-08-01
  • Lead Manager First Overseas Capital Limited
  • Registrar Bigshare Services Pvt Ltd
Market Lot Size

Investors can bid for a minimum of 1200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

ApplicationLotsSharesAmount
Retail (min)11200₹1,15,200
Retail(max)11200₹1,15,200
NII (min) 22,400₹2,30,400
Clinitech Laboratory Limited IPO Reservation

Clinitech Laboratory Limited IPO offers total 602,400 shares. Out of which NA (NA%) allocated to QIB, NA (NA%) allocated to NII,301,200 (50%) allocated to RII, NA (NA%) allocated to employees and NA (NA%) allocated to Anchor investors.

Investor CategoryShares OfferedMaximum Allottees
Anchor Investor Shares OfferedNA (NA%)
Market Maker Shares Offered31,200 (5.18%)
Retail Shares Offered301,200 (50%)
Total Shares Offered602,400 (100%)
Clinitech Laboratory Limited IPO Documents
Clinitech Laboratory Limited IPO Details


Clinitech Laboratory Limited IPO is an SME IPO, priced at ₹96 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the BSE SME platform. The IPO comprises a total issue of 6,02,400 equity shares, aggregating up to ₹5.78 crores..

The IPO bidding window is open from Jul 25, 2024 to Jul 29, 2024. The allotment is expected to be finalized on Jul 30, 2024, and the tentative listing date is Aug 1, 2024.

The minimum lot size for Retail investors is 1200 shares, with a minimum investment of ₹1,15,200. For HNIs, the minimum application size is 2 lots , amounting to ₹ 2,30,400.

First Overseas Capital Limited is acting as the lead manager to the issue. The registrar of the IPO is Bigshare Services Pvt Ltd, and Svcm Securities Private Limited will act as the market maker for this issue.

Read More
Clinitech Laboratory Limited IPO Subscription Analysis And Details
Retail
52.32x
Total
39.02x
As onQIB / NIIRetailTotal
Shares Offered / Reserved285,600285,600571,200
Day 1 25-07-24 06:00 PM
0.62 x4.33 x2.61 x
Day 2 26-07-24 06:00 PM
1.33 x10.10 x6.03 x
Day 3 29-07-24 06:00 PM
24.66 x52.32 x39.02 x

Total No of Applications
18,408
Clinitech Laboratory Limited Valuations
EPS Pre IPO ₹2.21/-
EPS Post IPO ₹1.63/-
P/E Pre IPO 43.45
P/E Post IPO 59.03
Debt/Equity 0.24
RoNW 10.46%
PAT Margin 5.76
Price to Book Value 4.55
Clinitech Laboratory Limited Company Financials
In Lakhs
In Lakh
31-Mar-2331-Mar-2231-Mar-21
Assets603.33368.74273.32
Revenue636.34645.70459.63
Profit After Tax61.3151.2640.24
About Clinitech Laboratory Limited Company

Clinitech Laboratory Limited was founded in 1990 and offers diagnostic and health testing, as well as services.

The company conducts more than 150 tests in its centres, categorized under such categories as Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests, and Histopathology Tests.

Eight diagnostic centers are scattered around Thane and Navi Mumbai. The firm conducts more than 3 lakh tests per year in its laboratories accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) well-equipped with the latest technology and high-quality machinery.

The testing facilities of Clinitech Laboratory for medical tests located at Airoli, Navi Mumbai are accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) as per ISO 15189:2012.

As of May 31, 2024, the company employed 85 people in various departments.

Read More
Clinitech Laboratory Limited - Promoter(s)

Jagdish Umakant Nayak

Jyoti Jagdish Nayak

Pre Issue Share Holding : 83.63%

Post Issue Share Holding : 61.56%

Clinitech Laboratory Limited IPO - Issue Objectives
1

Expansion of Diagnostic Centres

2

General Corporate Purposes.

Clinitech Laboratory Limited IPO - Peers Comparison
Company NameEPS (Basic)EPS (Diluted)NAV (per share) (Rs)P/E (x)RoNW (%)P/BV RatioFinancial statements
Clinitech Laboratory Limited2.37N/A21.1243.4510.464.55N/A
Dr Lalpath Labs43.05N/A225.8567.9219.1912.03Consolidated
Thyrocare Technologies Ltd13.42N/A99.6547.5613.176.41Consolidated
Krsnaa Diagnostics Limited17.9N/A250.7938.427.022.74Consolidated

Notes:

  1. The P/E Ratio is computed by dividing the Issue Price/closing market price on July 09, 2024, on BSE by EPS.
  2. RONW / EPS / NAV etc. is adjusted for face value.
  3. Clinitech financials are based on March 31, 2024, Restated Financials.
Contact Details

Clinitech Laboratory Limited

AL-1/545, Sector 16, Airoli, Opposite Radhikabai Meghe Vidyalaya, Navi Mumbai, Thane - 400708

+91 22 27792281

ipo@clinitechlab.com

https://clinitechlab.com/

Registrar Contact Details